Natco Pharma gets EIR for Kothur formulation facility
Natco Pharma announced closure of inspection with an Establishment Inspection Report (EIR) from USFDA for the pre-approval inspection conducted at its formulations facility in Kothur village, Telangana.
The announcement was made today, 25 April 2020. Shares of Natco Pharma rose 1.16% to close at Rs 624.35 on Friday.
Natco Pharma announced successful closure of inspection with an Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (FDA) for the pre-approval inspection conducted at its drug formulations facility in Kothur village, Telangana, during the period from 2nd March to 6th March 2020.
Natco Pharma is a pharmaceutical company. The company has seven manufacturing facilities spread across India with research laboratories, capabilities in New Drug Development, etc.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content